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Dendritic cell tumors are extremely rare neoplasms and occur both in nodal and extranodal sites. We report a case
of an intra-abdominal follicular dendritic cell sarcoma (FDCS). The aim of this study is to describe histological,
immunohistochemical, and ultrastructural features of FDCS in order to better define an abdominal mass with
unusual immunophenotype and atypical clinical and radiological presentation.Background
Dendritic cell tumors are rare entities which have been
previously described by a variety of terms such as lymph-
oma, sarcoma, or histiocytic neoplasms, reflecting the con-
troversy that surrounds these tumors [1]. Dendritic cells
originate from a heterogeneous group of non-lymphoid,
nonphagocytic immune accessory cells in lymphoid
districts or in non-lymphoid organs. Currently, these
elements are classified as follicular, interdigitating,
Langerhans’, and histiocytic/fibroblastic cells [2].
Dendritic cell neoplasms are illustrated by the occasional
occurrence of unremarkable clinical and radiological fea-
tures making a differential diagnosis challenging.
However, radiological and histological features can mimic
a wide variety of other tumors and tumor-like lesions,
among which mesenchymal tumors, spindle cell carcin-
omas, and inflammatory pseudotumors are the main
differential diagnoses. Even though imaging plays a fun-
damental role in the first diagnostic approach, histological
examination, immunohistochemical analysis, and possibly
electron microscopy provide the final diagnosis.
Here, we report clinicopathological, immunophenotypic,
ultrastructural, and imaging features of a case of intra-
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A 46-year-old male was referred to our hospital with acute
onset right flank abdominal pain with no other associated
symptoms. Physical examination revealed right upper
quadrant/flank tenderness, oral pemphigus, and undes-
cended testis. Clinical and oncological history was unre-
markable. The patient underwent a computed tomography
(CT) examination to further evaluate the abdominal pain
during emergency room work-out.
The CT images showed a 12-cm rounded mass of
heterogeneous solid tissue localized in the lower abdo-
men between intestinal loops; no enlarged lymph nodes
were observed. Coronal CT imaging showed a large mass
occupying most of the lower portion of the right abdomen
with a dyshomogeneous density due to cystic and nec-
rotic areas and no infiltration of the surrounding tissues
(Figure 1a). There were no calcifications in the mass; li-
quid in the pelvic cavity was detected. The tumor involved
the omolateral outer iliac vein as well as secondary dis-
location and suspect infiltration (Figure 1b).
A preoperative positron emission tomography (PET/CT)
scan was performed and showed a large 18 F-FDG
(fludeoxyglucose 18 F) avid mass in the lower right ab-
domen corresponding to the CT finding. The central
photopenic portion of the mass might be reflecting
necrotic processes (Figure 1c).
In order to characterize the lesion, we performed biop-
sies of the tumor using a CT-guided 18-gauge biopsy,
which revealed a poorly differentiated malignant neoplasm,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Coronal CT imaging. Coronal CT imaging showed a large mass occupying most of the lower portion of the right abdomen with a
dyshomogeneous density due to cystic and necrotic areas and no infiltration of the surrounding tissues (a). The tumor is located near the omolateral
outer iliac vein as well with secondary dislocation and suspect infiltration (b). In the PET/CT imaging, the central photopenic portion of the mass might
reflect necrotic process (c).
Figure 2 Gross specimen showed encapsulated solid mass,
yellowish-grey to tan, with focal microcystic spaces, with
scattered hemorrhage. An atrophic testis, free of tumor, was
also evident.
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not adequate for further analysis.
Patient was in good general health conditions, laboratory
tests were unremarkable, and the presurgical work-out
(electrocardiogram and chest X-ray) showed no contra-
indications to open major abdominal surgery.
The patient underwent resection of the mass through
a midline laparotomy incision. A tangential surgical resec-
tion of the venous vessel was necessary to ensure a correct
oncological debulking, since the right outer iliac vein infil-
tration could not be excluded by preoperative CT imaging.
The resection margins of the lesion and the dissected
lymph nodes were free of cancer cells, demonstrating
false-positive findings on imaging. Gross examination
of the specimen showed a 10-cm, encapsulated, nodular
mass, adjacent to a 1.8-cm cryptorchid testis with no tu-
moral infiltration. The mass had a firm, homogeneous
grey-tan cut surface, with few (<5%) areas of necrosis
and hemorrhage (Figure 2). After an extensive sampling
of the specimen, light microscopy revealed ovoid to spin-
dle cells arranged in a storiform proliferation, with a clus-
tering pattern of growth. This feature was embedded in a
heavy lymphoid stroma and a diffuse, thin-band interstitial
fibrosis. The neoplastic cells were characterized by an
abundant, eosinophilic cytoplasm, a finely dispersed
chromatin, and one or few evident nucleoli (Figure 3a).
Overall, the cytological features were uniform, with low-
grade atypia. Histological examination found scattered
bizarre, bi- or multinucleated giant cells. Mitotic count
was <10 mitoses/10 HPF and necrosis was focal. The
tumor was well-demarcated, without infiltration of thefibrous capsule thickness. These features, along with
the massive lymphoid stroma, suggested a nodal struc-
ture, although lymphoid follicles were not evident. Tak-
ing into consideration these features, we suspected a
nodal accessory-cell sarcoma. The neoplastic cells
stained strongly and diffusely for CD68 KP-1, and
weakly focally for CD45 and H-caldesmon (Figure 3b).
S-100 protein was positive in scattered cells, while
CD21, CD23, CD35, CD20, CD3, CD30, ALK-1, cyto-
keratin AE1/AE3, epithelial membrane antigen (EMA),
Figure 3 Histologic appearance and immunohistochemical findings of the FDC. (a) Histologic appearance of the follicular dendritic cell
sarcoma showing characteristic spindle and ovoid tumor cells with elongated nuclei and prominent nucleoli; note the presence of numerous
lymphocytes (hematoxylin and eosin staining, original magnification ×400). (b) Immunohistochemical findings of the FDC sarcoma; note the
expression of tumor cells for H-caldesmon in scattered cells (IHC staining, original magnification ×400).
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HMB-45, and melan-A were negative. Additionally, the
follicular dendritic cell markers CD21, CD23, and CD35
confirmed the absence of residual germinal centers. Ki67/
MIB-1 proliferation index was low (<5%). These morpho-
logical and immunophenotypical aspects were highly sus-
picious for a histiocytic/dendritic tumor; at the same time,
no feature was specific for a subtype. For this reason, an
ultrastructural study was considered necessary, and no
further immunohistochemical evaluation was performed.
Electron microscopy analysis revealed that tumor cells
were suitable for a follicular dendritic cell histogenesis
(interdigitating cell processes and desmosome junctions)
(Figure 4).
According to the 2008 WHO Classification of Tumours
of Haematopoietic and Lymphoid Tissues, the diagnosis
was nodal follicular dendritic cell sarcoma with atypicalFigure 4 Electron microscopy. Electron microscopy analysis
showed interdigitating cell processes and desmosome junctions
suggestive of a follicular dendritic histogenesis of the tumor.immunophenotype and myogenic/myofibroblastic differ-
entiation (H-caldesmon +) [3].
No residual disease was found in the testis and surgical
margins. Testicular parenchyma showed atrophy and hya-
linization of the tubules, with halt of maturation sequence
in germ lines.
Postoperative course was uneventful, and the patient was
discharged on the third postoperative day. After multidis-
ciplinary team discussion, no adjuvant treatment was
performed after the surgery. No recurrence occurred
after 1-year follow-up.
Discussion
Dendritic cell neoplasms are rare tumors that have been
previously described by a variety of terms such as lymph-
oma, sarcoma, or histiocytic neoplasm, reflecting the
controversy that surrounds these tumors [1].
Dendritic cells originate from a heterogeneous group
of non-lymphoid, nonphagocytic immune accessory cells
found in lymphoid and non-lymphoid organs; there are
several types of dendritic cells: follicular, interdigitating,
Langerhans’, and histiocytic/fibroblastic cells [2].
As previously described by some authors, dendritic cells
play a role in antigen capture and presentation, providing
structural and functional basis to the biochemical micro-
environment within the lymphoid tissue. Due to the
variety of dendritic cells and depending on the immu-
nophenotype, various histological subtypes of dendritic
cell neoplasms are present [2,4].
Follicular dendritic cell sarcoma (FDCS) is specifically
immunopositive to CD21, CD35, and/or CD23, vimentin,
fascin, HLA-DR, EMA, D2-40, clusterin, and CXCL13.
Immunohistochemical staining in the tumor cells is vari-
ously positive for S100, CD68, CD45, and CD20 [5].
The tumor was negative for classical markers CD21,
CD23, and EMA, while there was immunoreactivity
for H-caldesmon, which could indicate a myogenic/
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variant described in the WHO classification as ‘fibroblastic
reticular cell tumor,’ histologically similar to follicular or
interdigitating dendritic cell sarcoma, but lacks the immu-
nophenotypic profile of these tumor types (CD21, CD23,
or CD35 positivity).
Accordingly, the tumor shows variable immunoreactiv-
ity for myogenic markers and CD68 [3]. Prognosis of this
variant of dendritic cell sarcoma is similar to the classic
type.
The majority of dendritic cell neoplasms are benign/
low-grade soft tissue sarcomas, although rare highly ma-
lignant cases have been reported [5,6].
The differential diagnosis of FDCS includes other tumors
of histiocytic or dendritic origin. The differential diagnosis
from other types of tumor is important, since dendritic
cell neoplasm has a favorable prognosis whereas other
histiocytic/lymphoid tumors, such as histiocytic sarcoma,
can be more aggressive. It may be difficult to manage
these cases, and immunohistochemical markers (clusterin,
CXCL13, FDC markers) may help in making a correct
differential diagnosis [7,8].
FDCS has also to be distinguished from neurogenic
tumors, germ cell tumors, and mesenchymal tumors such
as solitary fibrous tumor, lipoma, epithelioid hemangioen-
dothelioma, and inflammatory pseudotumor.
Usually, dendritic cell neoplasms arise within the lymph
nodes, most commonly involving cervical and mediastinal
lymph nodes. Dendritic cell neoplasms can arise at extra-
nodal sites; an abdominal presentation, as in our case,
is extremely rare and literature reported only few stud-
ies. The challenging aspects of our case were the lower
abdominal location (into a lymph node near the undes-
cended testis), the clinical and radiological features, and
the fact that specimens obtained by CT biopsy were
unremarkable.
The majority of patients affected by this disease are
asymptomatic. The clinical presentation varies according
to the location of the primary tumor. Symptomatic
dendritic cell neoplasm typically presents as a painless,
slow-growing well-circumscribed mass, and no constitu-
tional symptoms, such as fever, night sweats, and weight
loss but in this case the oral pemphigus may be considered
as paraneoplastic syndrome. It is well known that oral
pemphigus, as in our case, and other cutaneous para-
neoplastic syndromes may precede, be concurrent with,
or follow the diagnosis of an underlying malignancy.
Usually FDCS and dendritic cell tumors are incidentally
discovered as a single intra-abdominal mass identified on
a CT scan (incidental finding).
All radiological features reported in literature, particularly
those relating to the CT imaging, showed typical morpho-
logical aspects of an expansive mass with an increasingly
inhomogeneous enhancement, directly proportional tolesion size (due to central necrosis, hemorrhage, and
cystic changes with a patchy pattern). Our case complied
with these features. There were no obvious pathogno-
monic radiological signs of dendritic cell neoplasm. Other
imaging modalities to investigate the abdominal mass are
the magnetic resonance and PET/CT imaging.
The principle of PET scan is based on human tissue
uptake of a glucose analog that has been tagged with a
positron-emitting isotope (18 F-FDG): this process is in-
tensified in malignant cells. In our case, the radiological
enlarged abdominal mass was secondary to areas of ne-
crosis (the central photopenic portion on PET scan con-
firmed by the macroscopic surgical specimen), given the
large size of the tumor. Moreover, the area of necrosis
was also confirmed by the macroscopic surgical specimen
during surgery.
Imaging techniques are fundamental in obtaining a pre-
liminary diagnosis based on morphological and functional
features of dendritic cell neoplasm, while the final diagno-
sis is determined by interventional approaches (biopsy or
surgery).
Morphological features, immunohistochemical analysis,
and electron microscopy are useful to obtain the final
diagnosis [9].
Most of the data on abdominal dendritic cell neoplasm
is based on case reports or small case series, and the nat-
ural history and response to different therapeutic modal-
ities in this disease have not been well established. To our
knowledge, there is no standard treatment algorithm in
such cases. Surgical resection remains the cornerstone
of treatment, while radiation therapy and chemotherapy
in the neoadjuvant, adjuvant, and metastatic setting are
yet undefined.Conclusions
Intra-abdominal dendritic cell neoplasm is extremely rare.
The pathologist should take this neoplasm into consid-
eration, due to differential diagnosis of unusual spindle
cell lesions (such as gastrointestinal stromal tumors or
solitary fibrous tumors) with a significant background
population of small lymphocytes. Only skilled pathologist
should perform differential diagnosis.
Due to its nonspecific histologic appearance, additional
electron microscopic studies are generally required to de-
fine the correct diagnosis and the histological subtype.
Although surgery, whenever feasible, is the primary treat-
ment, multimodality approach and patient-related treat-
ment should be considered.
Further studies are necessary to manage these particular
patients.Consent
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